List view / Grid view
13 October 2011 | By Merck
Exploratory pre-specified analyses from the ongoing STARTMRK Phase III study results...
12 October 2011 | By kdm communications
Tecan will distribute Attana's label-free biosensor instruments and quartz crystal microbalance (QCM) assay technology...
11 October 2011 | By kdm communications limited
Frimley Park Hospital in Surrey, UK, has recently invested in Radiometer’s AQT90 FLEX system...
11 October 2011 | By BMG LABTECH
BMG LABTECH now offers the Atmospheric Control Unit (ACU)...
10 October 2011 | By Roche
Monoclonal antibody gantenerumab removes amyloid plaques from the brain...
10 October 2011 | By Novo Nordisk
Victoza® (liraglutide injection), is now commercially available in China...
10 October 2011 | By AstraZeneca
AstraZeneca announced a $200 million investment in a new manufacturing facility...
7 October 2011 | By bioMérieux
bioMérieux, is expanding its culture media expertise center in Craponne (France)...
7 October 2011 | By Eli Lilly and Company
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil) tablets for once daily use for the treatment of men who have both erectile dysfunction and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). The FDA also approved Cialis…
7 October 2011 | By Teva UK Ltd
Teva UK Ltd announce the off-patent launch of generic Olanzapine Teva Film-Coated Tablets & Olanzapine Teva Orodispersible Tablets...
7 October 2011 | By Merck
Multiple national guidelines recommend that patients with type 2 diabetes be treated for cholesterol...
6 October 2011 | By kdm communications
This year’s Tecan Symposium will be held in Shanghai, China, from the 2nd to 4th of November...
6 October 2011 | By Merck
Merck announced that Richard T. Clark, chairman, will retire 1st December ...
5 October 2011 | By Merck
The FDA accepted for filing and review the New Drug Application for ridaforolimus...
5 October 2011 | By Gilead Sciences
Gilead Sciences, Inc. and Boehringer Ingelheim have entered into a licensing agreement...
